195 related articles for article (PubMed ID: 26065034)
1. E10A, an adenovirus carrying human endostatin gene, in combination with docetaxel treatment inhibits prostate cancer growth and metastases.
Zhao P; Luo R; Wu J; Xie F; Li H; Xiao X; Fu L; Zhu X; Liu R; Zhu Y; Liang Z; Huang W
J Cell Mol Med; 2010 Jan; 14(1-2):381-91. PubMed ID: 26065034
[TBL] [Abstract][Full Text] [Related]
2. E10A, an adenovirus-carrying endostatin gene, dramatically increased the tumor drug concentration of metronomic chemotherapy with low-dose cisplatin in a xenograft mouse model for head and neck squamous-cell carcinoma.
Adhim Z; Lin X; Huang W; Morishita N; Nakamura T; Yasui H; Otsuki N; Shigemura K; Fujisawa M; Nibu K; Shirakawa T
Cancer Gene Ther; 2012 Feb; 19(2):144-52. PubMed ID: 22116375
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy of androgen-independent prostate cancer using a prostate restricted replicative adenovirus and a replication-defective adenovirus encoding human endostatin-angiostatin fusion gene.
Li X; Raikwar SP; Liu YH; Lee SJ; Zhang YP; Zhang S; Cheng L; Lee SD; Juliar BE; Gardner TA; Jeng MH; Kao C
Mol Cancer Ther; 2006 Mar; 5(3):676-84. PubMed ID: 16546982
[TBL] [Abstract][Full Text] [Related]
4. Cotargeting tumor and tumor endothelium effectively inhibits the growth of human prostate cancer in adenovirus-mediated antiangiogenesis and oncolysis combination therapy.
Jin F; Xie Z; Kuo CJ; Chung LW; Hsieh CL
Cancer Gene Ther; 2005 Mar; 12(3):257-67. PubMed ID: 15565180
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral vectors expressing human endostatin-angiostatin and soluble Tie2: enhanced suppression of tumor growth and antiangiogenic effects in a prostate tumor model.
Raikwar SP; Temm CJ; Raikwar NS; Kao C; Molitoris BA; Gardner TA
Mol Ther; 2005 Dec; 12(6):1091-100. PubMed ID: 16169279
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of recombinant human endostatin and docetaxel on human umbilical vein endothelial cells in different growth states.
Xu WJ; Huang C; Wang J; Jiang RC; Wang LC; Lin L; Liu ZJ; Sun BC; Li K
Chin Med J (Engl); 2011 Sep; 124(18):2883-9. PubMed ID: 22040497
[TBL] [Abstract][Full Text] [Related]
7. Prostate-restricted replicative adenovirus expressing human endostatin-angiostatin fusion gene exhibiting dramatic antitumor efficacy.
Li X; Liu YH; Lee SJ; Gardner TA; Jeng MH; Kao C
Clin Cancer Res; 2008 Jan; 14(1):291-9. PubMed ID: 18172281
[TBL] [Abstract][Full Text] [Related]
8. Combined effects of docetaxel and angiostatin gene therapy in prostate tumor model.
Galaup A; Opolon P; Bouquet C; Li H; Opolon D; Bissery MC; Tursz T; Perricaudet M; Griscelli F
Mol Ther; 2003 Jun; 7(6):731-40. PubMed ID: 12788646
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of growth and metastasis of orthotopic human prostate cancer in athymic mice by combination therapy with pegylated interferon-alpha-2b and docetaxel.
Huang SF; Kim SJ; Lee AT; Karashima T; Bucana C; Kedar D; Sweeney P; Mian B; Fan D; Shepherd D; Fidler IJ; Dinney CP; Killion JJ
Cancer Res; 2002 Oct; 62(20):5720-6. PubMed ID: 12384530
[TBL] [Abstract][Full Text] [Related]
10. Liposome transfected to plasmid-encoding endostatin gene combined with radiotherapy inhibits liver cancer growth in nude mice.
Zheng AQ; Song XR; Yu JM; Wei L; Wang XW
World J Gastroenterol; 2005 Jul; 11(28):4439-42. PubMed ID: 16038050
[TBL] [Abstract][Full Text] [Related]
11. Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects.
Abdollahi A; Lipson KE; Sckell A; Zieher H; Klenke F; Poerschke D; Roth A; Han X; Krix M; Bischof M; Hahnfeldt P; Grone HJ; Debus J; Hlatky L; Huber PE
Cancer Res; 2003 Dec; 63(24):8890-8. PubMed ID: 14695206
[TBL] [Abstract][Full Text] [Related]
12. A phase I clinical trial of an adenovirus-mediated endostatin gene (E10A) in patients with solid tumors.
Lin X; Huang H; Li S; Li H; Li Y; Cao Y; Zhang D; Xia Y; Guo Y; Huang W; Jiang W
Cancer Biol Ther; 2007 May; 6(5):648-53. PubMed ID: 17426445
[TBL] [Abstract][Full Text] [Related]
13. [Inhibition of tumor growth and metastasis via local administration of recombinant human endostatin adenovirus].
Wu Y; Yang L; Zhao X; Su JM; Hu B; Liu JY; Niu T; Luo Y; Li Q; Wei YQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):557-61. PubMed ID: 15583981
[TBL] [Abstract][Full Text] [Related]
14. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
Wang H; Wei F; Li H; Ji X; Li S; Chen X
Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
[TBL] [Abstract][Full Text] [Related]
15. Concurrent chemoradiotherapy with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenografts.
Wang L; Huang X; Zheng X; Wang X; Li S; Zhang L; Yang Z
Clin Transl Oncol; 2014 Jun; 16(6):567-72. PubMed ID: 24105048
[TBL] [Abstract][Full Text] [Related]
16. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and docetaxel in a human prostate cancer PC-3 model.
Muramaki M; Miyake H; Hara I; Kamidono S
Int J Oncol; 2005 Mar; 26(3):623-8. PubMed ID: 15703816
[TBL] [Abstract][Full Text] [Related]
17. GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells.
Karanika S; Karantanos T; Kurosaka S; Wang J; Hirayama T; Yang G; Park S; Golstov AA; Tanimoto R; Li L; Thompson TC
Mol Cancer; 2015 Jun; 14():122. PubMed ID: 26084402
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy with the angiogenesis inhibitor endostatin in an orthotopic lung cancer murine model.
Ning T; Yan X; Lu ZJ; Wang GP; Zhang NG; Yang JL; Jiang SS; Wu Y; Yang L; Guan YS; Luo F
Hum Gene Ther; 2009 Feb; 20(2):103-11. PubMed ID: 18939902
[TBL] [Abstract][Full Text] [Related]
19. Docetaxel increases antitumor efficacy of oncolytic prostate-restricted replicative adenovirus by enhancing cell killing and virus distribution.
Li X; Liu Y; Tang Y; Roger P; Jeng MH; Kao C
J Gene Med; 2010 Jun; 12(6):516-27. PubMed ID: 20527044
[TBL] [Abstract][Full Text] [Related]
20. Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells.
Dkhissi F; Lu H; Soria C; Opolon P; Griscelli F; Liu H; Khattar P; Mishal Z; Perricaudet M; Li H
Hum Gene Ther; 2003 Jul; 14(10):997-1008. PubMed ID: 12869217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
